Clinicopathological Significance and Diagnostic Accuracy of c-MET Expression by Immunohistochemistry in Gastric Cancer: A Meta-Analysis. - Wikidata - awgldk - TriplyDB

Clinicopathological Significance and Diagnostic Accuracy of c-MET Expression by Immunohistochemistry in Gastric Cancer: A Meta-Analysis.

Clinicopathological Significance and Diagnostic Accuracy of c-MET Expression by Immunohistochemistry in Gastric Cancer: A Meta-Analysis.

http://www.wikidata.org/entity/Q37342442

about

A non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer.Current therapeutic landscape for advanced gastroesophageal cancers.

P2860

Q44303811-D54CD349-C0A6-4297-87F7-6B148899CDFC Q52581752-B629C561-3598-4614-8571-75EBF3AE0DD2

P2860

Clinicopathological Significance and Diagnostic Accuracy of c-MET Expression by Immunohistochemistry in Gastric Cancer: A Meta-Analysis.

http://www.wikidata.org/entity/Q37342442

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinicopathological Significan ...... stric Cancer: A Meta-Analysis.

@en

Clinicopathological Significan ...... stric Cancer: A Meta-Analysis.

@nl

type

label

Clinicopathological Significan ...... stric Cancer: A Meta-Analysis.

@en

Clinicopathological Significan ...... stric Cancer: A Meta-Analysis.

@nl

prefLabel

Clinicopathological Significan ...... stric Cancer: A Meta-Analysis.

@en

Clinicopathological Significan ...... stric Cancer: A Meta-Analysis.

@nl

P1433

Q37342442-6DBCE497-87BD-45EB-BB45-04DA86967F97

P1476

Q37342442-00F3F191-05FC-4336-997F-F706951F24FB

P2093

Q37342442-C9116C44-002B-4008-B81D-9EDEF439415D

Q37342442-CA8A8C73-CD7B-4364-84C9-3B2C2A180FEE

Q37342442-CF788080-FCAD-41C2-9CB9-C37E36DF6130

P2860

Q37342442-029F299C-A6D1-47B0-8067-01B97A2A7009

Q37342442-04AB1D3E-3E51-43F1-B6CB-A41C58F1B1DD

Q37342442-04C28FE1-863D-484B-8801-E480D5773CD2

Q37342442-05F3A368-2AB6-4172-800C-F3565A819E3D

Q37342442-09734824-15DC-4480-9073-09E813804AFF

Q37342442-166A2F83-EEE9-45F8-A6DC-F3A4EB809E09

Q37342442-205DA55E-2390-4DA9-970D-838AD74070FE

Q37342442-2321C476-2434-4B18-AC91-62348AA4FFF3

Q37342442-2D6FEEB4-6A8A-4E6C-A498-C4737DEB7B43

Q37342442-300CA6B2-0D18-416D-B59C-9603852DB84E

P304

Q37342442-FFA725BB-CE22-4D5C-84F5-571B85F64683

P31

Q37342442-CDB39634-1E47-477B-B984-EDA908DBD2DB

P356

Q37342442-8B498C11-24A6-4A20-B244-FD47DF2064BC

P433

Q37342442-CD35BD3D-D993-4544-92B3-81BB1323095A

P478

Q37342442-42FCA69F-AA9E-4A83-A121-29411F1BD4FB

P577

Q37342442-A2D299B1-DA7E-4B97-8348-FB90264E0DAE

P698

Q37342442-F86BDA1E-1982-46DB-AA65-1F7CAD194173

P921

Q37342442-391bed55-0a85-4403-8230-3416a578f595

Q37342442-DACBADCE-CAC3-4BE6-ADE3-135C4CE15356

P932

Q37342442-7E6AB2A6-923B-4544-8A5F-30E57556B7D4

P356

JGC.2016.16.3.141

P1433

Journal of gastric cancer

P1476

Clinicopathological Significan ...... stric Cancer: A Meta-Analysis.

@en

P2093

Guhyun Kang

http://www.w3.org/2001/XMLSchema#string

Hyunjin Cho

http://www.w3.org/2001/XMLSchema#string

Jung-Soo Pyo

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical significance of MET in gastric cancer

Prognostic significance of MET amplification and expression in gastric cancer: a systematic review with meta-analysis

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

Meta-DiSc: a software for meta-analysis of test accuracy data.

Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study.

Expression of MACC1 and c-Met in human gastric cancer and its clinical significance.

Developing c-MET pathway inhibitors for cancer therapy: progress and challenges.

Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations.

Analysis of MET mRNA expression in gastric cancers using RNA in situ hybridization assay: its clinical implication and comparison with immunohistochemistry and silver in situ hybridization.

P304

141-151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5230/JGC.2016.16.3.141

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27752391

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry

P932

5065943

http://www.w3.org/2001/XMLSchema#string